Seguir
Juan Esteban Arango Ossa
Juan Esteban Arango Ossa
Otros nombresJuan E. Arango, Juan E. Arango-Ossa
Dirección de correo verificada de mskcc.org - Página principal
Título
Citado por
Citado por
Año
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
E Bernard, Y Nannya, RP Hasserjian, SM Devlin, H Tuechler, ...
Nature medicine 26 (10), 1549-1556, 2020
4472020
Cancer therapy shapes the fitness landscape of clonal hematopoiesis
KL Bolton, RN Ptashkin, T Gao, L Braunstein, SM Devlin, D Kelly, M Patel, ...
Nature genetics 52 (11), 1219-1226, 2020
4222020
Molecular international prognostic scoring system for myelodysplastic syndromes
E Bernard, H Tuechler, PL Greenberg, RP Hasserjian, JE Arango Ossa, ...
NEJM evidence 1 (7), EVIDoa2200008, 2022
3732022
3D ultrafast ultrasound imaging in vivo
J Provost, C Papadacci, JE Arango, M Imbault, M Fink, JL Gennisson, ...
Physics in Medicine & Biology 59 (19), L1, 2014
3492014
Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesis
T Gao, R Ptashkin, KL Bolton, M Sirenko, C Fong, B Spitzer, ...
Nature communications 12 (1), 338, 2021
782021
Unified classification and risk-stratification in acute myeloid leukemia
Y Tazi, JE Arango-Ossa, Y Zhou, E Bernard, I Thomas, A Gilkes, ...
Nature Communications 13 (1), 1-16, 2022
732022
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia
J Mascarenhas, HE Kosiorek, JT Prchal, A Rambaldi, D Berenzon, ...
Blood, The Journal of the American Society of Hematology 139 (19), 2931-2941, 2022
622022
Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma
V Yellapantula, M Hultcrantz, EH Rustad, E Wasserman, D Londono, ...
Blood cancer journal 9 (12), 101, 2019
502019
Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase
JO Mascarenhas, RK Rampal, HE Kosiorek, R Bhave, E Hexner, ...
Blood advances 4 (20), 5246-5256, 2020
472020
Accelerated single cell seeding in relapsed multiple myeloma
HJ Landau, V Yellapantula, BT Diamond, EH Rustad, KH Maclachlan, ...
Nature communications 11 (1), 3617, 2020
432020
Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers
N Shukla, MF Levine, G Gundem, D Domenico, B Spitzer, N Bouvier, ...
Nature communications 13 (1), 2485, 2022
292022
Sistema para rehabilitacion del sindrome del miembro fantasma utilizando interfaz cerebro-computador y realidad aumentada
JE Arango, JC Mazo, A PeñaPalacio
Revista Ibérica de Sistemas e Tecnologias de Informação, 93, 2013
292013
Isabl Platform, a digital biobank for processing multimodal patient data
JS Medina-Martínez, JE Arango-Ossa, MF Levine, Y Zhou, G Gundem, ...
BMC bioinformatics 21, 1-18, 2020
272020
TP53 state dictates genome stability, clinical presentation and outcomes in myelodysplastic syndromes
E Bernard, Y Nannya, T Yoshizato, RP Hasserjian, R Saiki, Y Shiozawa, ...
Blood 134, 675, 2019
232019
Transient expansion of TP53 mutated clones in polycythemia vera patients treated with idasanutlin
BK Marcellino, N Farnoud, B Cassinat, M Lu, E Verger, E McGovern, ...
Blood advances 4 (22), 5735-5744, 2020
212020
Oncologic therapy shapes the fitness landscape of clonal hematopoiesis
KL Bolton, RN Ptashkin, T Gao, L Braunstein, SM Devlin, D Kelly, M Patel, ...
BioRxiv, 848739, 2019
212019
Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures
B Diamond, B Ziccheddu, K Maclachlan, J Taylor, E Boyle, JA Ossa, ...
Blood, The Journal of the American Society of Hematology 141 (19), 2359-2371, 2023
122023
Treatment of myelofibrosis patients with the TGF-β 1/3 inhibitor AVID200 (MPN-RC 118) induces a profound effect on platelet production
J Mascarenhas, HE Kosiorek, R Bhave, JM Palmer, AT Kuykendall, ...
Blood 138, 142, 2021
112021
Molecular international prognostic scoring system for myelodysplastic syndromes. NEJM Evid; 2022
E Bernard, H Tuechler, PL Greenberg, RP Hasserjian, JEA Ossa, ...
11
Landscape of TP53 mutations in MPN
N Farnoud, C Famulare, E Papaemmanuil, E McGovern, J Medina, ...
Blood 134, 1681, 2019
92019
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20